• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FDA frees Biopure inventory

March 1, 2003

Cambridge, Mass.-Biopure Corp. started shipping Oxyglobin to U.S. veterinary hospitals in mid February following a nod from the U.S. Food and Drug Administration (FDA) to do so.

FDA and the company resolved its previously reported "manufacturingdocumentation issue" and the company since lifted its voluntary holdon Oxyglobin inventory. Biopure has produced and inventoried more than 20,000units of Oxyglobin since its recently expanded manufacturing facilitiesreopened, which it will use to fill more than 11,000 units on backorderbeginning in mid February, and it is continuing to manufacture new productlots for sale.

"We're grateful for our valued customers' patience and support,and we're committed to providing an uninterrupted supply of product nowthat shipments are resuming," says Rick Merrill, Biopure's directorof veterinary sales. Backorders will be filled as quickly as possible inthe order they were received, the company adds. Veterinary customers shoulddirect any shipment-related questions to Oxyglobin customer service at (888)337-0929 or rbettger@biopure.com.

"We're delighted to have this issue resolved and be back in businesswith Oxyglobin," says Biopure President and CEO Thomas A. Moore.

Oxyglobin, an oxygen therapeutic approved by FDA and the European Commission,is indicated for the treatment of anemia in dogs by increasing systemicoxygen content and improving the clinical signs associated with anemia.

Advertisement

The product has been widely used both as an alternative to red bloodcell transfusion (e.g., massive blood loss) and in situations where immediateoxygen-carrying support may be beneficial but blood transfusion is ineffectiveor inappropriate (e.g., immune-mediated hemolytic anemia).

These usage patterns encompass a variety of critical conditions. Unlikedonated blood, Oxyglobin is compatible with all blood types, is stable atroom temperature (2º to 30ºC) for three years, and goes througha pharmaceutical manufacturing process that is validated to remove potentialcontaminants.

Related Content:

Regulatory
What you need to know about GFI #256 and the changing landscape of compounding medicine
What you need to know about GFI #256 and the changing landscape of compounding medicine
3 common misconceptions in controlled substance regulations
3 common misconceptions in controlled substance regulations
FDA hosts virtual listening session on regulation of animal food
FDA hosts virtual listening session on regulation of animal food

Advertisement

Latest News

The four-letter word to why you're burning out and feeling unproductive

Merck Manuals recognizes importance of One Health concept

Topical therapy and immunotherapy can save time and frustration with dermatology cases

Texas Tech appoints new faculty member with passion for animal agriculture

View More Latest News
Advertisement